Background: Many intracranial lesions can induce psychotic symptoms. Arachonoid cyst is one of the suspicious etiologies. A possible link between arachnoid cyst and psychosis gives an interest to the pathogenesis of psychotic symptoms. Here, we present a case of schizophrenia with a large cerebellar arachnoid cyst. Case Presentation: Ms. Lu is a 31-year-old woman with schizophrenia for 7 years without regular treatment. She was admitted because of auditory hallucinations, referential and persecutory delusions accompanying irritable mood and aggressive behaviors. She described that her parents were evil and wanted her to die. Series of examinations were arranged. Neurological examination revealed some stereotype behaviors and easily falling down. The blood counts, serum chemistry and EEG were normal. Brain MRI revealed an arachnoid cyst about 6.9 x 4.1 x 3.1 cm over right posterior fossa with cerebellar compression. Neurosurgery was consulted and no emergent pathologic change was detected, then routine follow-up was recommended. Her psychotic and aggressive symptoms gradually improved under Olanzapine 30mg/day and Depakine 1200mg/day. Brain Imaging:
Discussion: It is difficult to ascertain whether cerebellar arachnoid cyst influences psychotic symptoms. I speculate that cerebellar arachnoid cyst is associated with schizophrenia in this case for following reasons: (1) Cerebellum is crucial in cognition and several psychiatric disorders including schizophrenia. (2) Ms. Lu has soft stereotype behaviors and easily falling down with psychotic symptoms. (3) The cyst was large enough to compress right lobe and adjacent structures. (4) Ms. Lu was unresponsive to regular-dose Olanzapine (20mg/day) monotherapy and required Olanzapine 30mg/day and additional Depakine 1200mg/day. In the literature review, misconnections between cortex and cerebellum through thalamus (Cortico-cerebellar-thalamic-cortical circuit) may explain part of schizophrenic symptoms. I propose that Ms. Lu's arachnoid cyst at right posterior fossa with cerebellar compression may cause abnormality in above circuit and result in psychotic symptoms. Further research is warranted to elucidate underlying mechanisms. Keywords: cerebellum, arachnoid cyst, schizophrenia
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Brain metabolite differences in subjects with high genetic risk of schizophrenia using 1H magnetic resonance spectroscopy H-MRS studies on schizophrenia reported the abnormal concentration of N-acetyl aspartate (NAA) and glutamate / glutamine. We hypothesize that the alteration exists in the individuals with a high genetic risk of schizophrenia and the alteration would be associated with their genetic loading. Methods: The concentration of brain metabolites in the anterior cingulate cortex, left dorsolateral prefrontal cortex, left thalamus was acquired using 1 H-MRS at 3 Tesla from 24 participants. The participants comprise of 12 high genetic risk group, who had at least two relatives with schizophrenia and 12 age-and gender-matched controls. We assessed the association between brain metabolite concentration and the genetic loading. Results: Compared to healthy controls, the high genetic risk group demonstrated increment in glutamate / glutamine concentrations in anterior cingulate cortex and thalamus. The NAA level was significantly increased in the thalamus. The increased level of the glutamate / glutamine was significantly correlated with the individual's genetic loadings. Discussion: Our results suggest that the high genetic risk group demonstrates the similar pattern of alterations in glutamate / glutamine level with those observed in schizophrenia. However, in contrary to previous schizophrenia studies, NAA level was increased suggesting that the compensatory neuroplasticity mechanism may exist in the high genetic risk group. The altered glutamate / glutamine level at the thalamus was correlated with the individual's genetic loading, suggesting that the aberrant brain metabolite at the thalamus could be considered as a genetic vulnerability marker.
